Spring direct naar de hoofdnavigatie of de inhoud

Life Sciences

In life sciences, including biotechnology, V.O. represents clients in a broad range of traditional pharmaceutical as well as biological technologies, including immunology, virology, molecular biology, animal and plant genetics, gene therapy, protein chemistry, pharmacology, enzymology, bioinformatics and others. Specific areas of expertise include among others diagnostics, recombinant cytokines, antibody technology, personalized medicine, biomarkers, recombinant antigens and vaccines, and antisense and small RNA technology.

From start-ups to multinationals

Our client base in the life sciences and biotechnology sector ranges from biotech start-ups to multinationals. Working for and with biotech start-ups requires a special approach, as balancing research and commercial development may be complex. The long-term IP strategy, for instance, in which the patent portfolio should be attractive to possible investors and licensees, sometimes seems at odds with the short-term company policy. We know exactly how to provide solutions that are workable and effective.

Renowned experts

Our patent attorneys include renowned experts in biotech and life sciences. Some have worked in the life sciences industry, for instance as researcher. All of them are highly dedicated to their profession, and see it as their mission to help companies to build up a sound and balanced IP portfolio that enables these companies to keep up the good work.

Full-service partner

We provide all IP services: drafting and prosecuting patent applications all over the world. We assist you in defending or attacking patents; in infringement suits and in opposition or invalidity proceedings. Other fields of activity are Freedom To Operate analysis, IP audits and Supplementary Protection Certificates for pharmaceuticals and agrochemicals. Particularly for biotech start-ups we commit ourselves to supporting you throughout the different developmental stages of your company. We help you to integrate IP into your operational management and materialize the knowledge assets of your company.

Contact our experts

Bettina Hermann

Bettina Hermann

  • European and German Patent and Trademark Attorney, European Patent Litigator
  • Partner
More experts

News

T 1186/24: claim wording determines the scope of sufficiency analysis

Claim interpretation can determine whether the invention is sufficiently disclosed In T 1186/24, Technical Board of Appeal 3.3.08, 18 June 2026, the European Patent Office (EPO) considered how the wording of a claim affects the assessment of sufficiency of disclosure. The Board held that an expressly claimed alternative could not be read out of the […]Continue reading

The license of right for the unitary patent: smart cost saving or strategic limitation?

With the introduction of the European patent with unitary effect (unitary patent or UP), patent holders now have access to new strategic tools. One of these is the license of right (LoR). What does such a declaration entail, and what advantages and disadvantages can it have for the protection of your intellectual property?Continue reading

UPC jurisdiction over UK designations and conditional infringement relief in Fujifilm v Kodak

In the case of Kodak vs. Fujifilm concerning EP 3 511 174 on 2 June 2026 before the Court of Appeal of the Unified Patent, the Court of Appeal addressed the UPC’s jurisdiction over the UK designation of a European patent. The decision is important because it applies the CJEU’s reasoning in BSH v Electrolux […]Continue reading

Events

FICPI 23rd Open Forum

Budapest, Corinthia Budapest, Erzsébet körút, Hungary

The FICPI 23rd Open Forum provides excellent opportunities to build strong relationships by connecting groups of people who share common goals, concerns and a commitment to quality, as well as opportunities to gather insights from the international IP attorney community on IP practice-related issues or topics of IP law and hear from top-quality speakers.

Continue reading

Med-Tech Innovation & Licensing Day

High Tech Campus Eindhoven, High Tech Campus, Eindhoven

Collaborating to Commercialize Healthcare Innovation: From Research to Patient Impact

Continue reading